Compare AbCellera Biologics Inc (ABCL) vs Snowflake Inc (SNOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Snowflake Inc — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Snowflake Inc trades at $332.7 (market cap $116.01B). The key difference: Snowflake Inc is far larger — about 38.8× AbCellera Biologics Inc's market cap. Which is the better fit depends on your goals.
| ABCL | SNOW | |
|---|---|---|
Market Cap | $2.99B | $116.01B |
Sector | Health | Technology |
52-Week High | $9.76 | $334.70 |
52-Week Low | $2.78 | $121.11 |
Enterprise Value | $2.58B | $115.82B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
